(19)
(11) EP 0 971 910 A1

(12)

(43) Date of publication:
19.01.2000 Bulletin 2000/03

(21) Application number: 98913487.9

(22) Date of filing: 31.03.1998
(51) International Patent Classification (IPC)7C07D 307/58, A61K 31/34, C07D 405/06, C07C 317/24, C07C 317/14
(86) International application number:
PCT/CA9800/302
(87) International publication number:
WO 9843/966 (08.10.1998 Gazette 1998/40)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30) Priority: 02.04.1997 US 42535 P
07.05.1997 GB 9709356

(71) Applicant: Merck Frosst Canada & Co.
Kirkland, Quebec H9H 3L1 (CA)

(72) Inventors:
  • LEGER, Serge
    Kirkland, Quebec H9H 3L1 (CA)
  • GRIMM, Erich
    Kirkland, Quebec H9H 3L1 (CA)
  • PRASIT, Petpiboon
    Kirkland, Quebec H9H 3L1 (CA)

(74) Representative: Horgan, James Michael Frederic et al
Merck & Co., Inc.,Terlings Park,Eastwick Road
Harlow,Essex CM20 2QR
Harlow,Essex CM20 2QR (GB)

   


(54) ALPHA-METHYLENE GAMMA LACTONES AS SELECTIVE CYCLOOXYGENASE-2 INHIBITORS